Trial Profile
A Phase III, multicentre, randomized, observer blind, parallel group, three arms, controlled clinical trial to evaluate the efficacy and safety of topically applied Calcipotriol/AKVANO 50 μg/g cutaneous solution against Calcipotriol Ointment 50 micrograms/g, Sandoz and placebo in patients with mild to moderate plaque psoriasis-CRSC16004
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Mar 2022
Price :
$35
*
At a glance
- Drugs Calcipotriol (Primary) ; Calcipotriol
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Cadila Pharmaceuticals
- 24 Jan 2020 According to a Lipidor media release, this study was conducted in collaboration with Cerbios-Pharma SA.
- 24 Jan 2020 According to a Lipidor media release, evaluation of secondary endpoints as well as more detailed analysis of the study results will now be started.
- 24 Jan 2020 Results presented in a Lipidor AB Media Release.